Cookies?
Library Header Image
LSE Research Online LSE Library Services

Measuring performance in off-patent drug markets: a methodological framework and empirical evidence from twelve EU Member States

Kanavos, Panos (2014) Measuring performance in off-patent drug markets: a methodological framework and empirical evidence from twelve EU Member States. Health Policy, 118 (2). pp. 229-241. ISSN 0168-8510

[img]
Preview
PDF - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (1MB) | Preview
Identification Number: 10.1016/j.healthpol.2014.08.005

Abstract

This paper develops a methodological framework to help evaluate the performance of generic pharmaceutical policies post-patent expiry or after loss of exclusivity in non-tendering settings, comprising five indicators (generic availability, time delay to and speed of generic entry, number of generic competitors, price developments, and generic volume share evolution) and proposes a series of metrics to evaluate performance. The paper subsequently tests this framework across twelve EU Member States (MS) by using IMS data on 101 patent expired molecules over the 1998-2010 period. Results indicate that significant variation exists in generic market entry, price competition and generic penetration across the study countries. Size of a geographical market is not a predictor of generic market entry intensity or price decline. Regardless of geographic or product market size, many off patent molecules lack generic competitors two years after loss of exclusivity. The ranges in each of the five proposed indicators suggest, first, that there are numerous factors - including institutional ones - contributing to the success of generic entry, price decline and market penetration and, second, MS should seek a combination of supply and demand-side policies in order to maximise cost-savings from generics. Overall, there seems to be considerable potential for faster generic entry, uptake and greater generic competition, particularly for molecules at the lower end of the market.

Item Type: Article
Official URL: http://www.journals.elsevier.com/health-policy/
Additional Information: © 2014 Elsevier Ireland Ltd.
Divisions: European Institute
Social Policy
LSE Health
Subjects: H Social Sciences > HN Social history and conditions. Social problems. Social reform
Sets: Departments > European Institute
Departments > Social Policy
Research centres and groups > LSE Health
Date Deposited: 29 Sep 2014 16:22
Last Modified: 20 Jun 2019 01:58
URI: http://eprints.lse.ac.uk/id/eprint/59567

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics